Grégory Driessens

3.3k total citations · 2 hit papers
35 papers, 2.4k citations indexed

About

Grégory Driessens is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Grégory Driessens has authored 35 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 15 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Grégory Driessens's work include Immune Cell Function and Interaction (14 papers), CAR-T cell therapy research (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Grégory Driessens is often cited by papers focused on Immune Cell Function and Interaction (14 papers), CAR-T cell therapy research (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Grégory Driessens collaborates with scholars based in Belgium, United States and Romania. Grégory Driessens's co-authors include Thomas F. Gajewski, Cédric Blanpain, Benjamin Beck, Benjamin D. Simons, Candace M. Cham, James P. O’Keefe, Justin Kline, Gaëlle Lapouge, Sandrine Lenglez and Isabelle Salmon and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Grégory Driessens

34 papers receiving 2.3k citations

Hit Papers

Defining the mode of tumour growth by clonal analysis 2012 2026 2016 2021 2012 2014 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Defining the mode of tumour growth by clonal analysis
    2012 547 citations Grégory Driessens, Benjamin Beck et al. Nature profile →
  2. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma
    2014 521 citations Soufiane Boumahdi, Grégory Driessens et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grégory Driessens Belgium 13 1.2k 1.2k 712 616 197 35 2.4k
Rubén A. Bartolomé Spain 29 1.1k 0.9× 1.0k 0.8× 648 0.9× 493 0.8× 313 1.6× 48 2.3k
Jürgen Dittmer Germany 23 1.3k 1.0× 783 0.6× 447 0.6× 493 0.8× 140 0.7× 44 2.2k
Kristin J. Hope Canada 17 1.6k 1.3× 1.1k 0.9× 573 0.8× 428 0.7× 247 1.3× 38 2.9k
Stephin J. Vervoort Australia 26 1.4k 1.1× 858 0.7× 768 1.1× 361 0.6× 93 0.5× 49 2.4k
Klara Balint United States 15 1.2k 1.0× 1.4k 1.1× 1.4k 2.0× 454 0.7× 151 0.8× 20 2.7k
Steven Goossens Belgium 26 1.9k 1.5× 805 0.7× 409 0.6× 649 1.1× 356 1.8× 71 3.0k
Isabelle Bourget France 24 1.0k 0.8× 625 0.5× 395 0.6× 500 0.8× 261 1.3× 32 1.9k
Koichi Sakakura Japan 22 758 0.6× 1.0k 0.8× 698 1.0× 387 0.6× 180 0.9× 53 1.9k
Dolores Martínez Spain 16 1.7k 1.4× 478 0.4× 735 1.0× 580 0.9× 127 0.6× 22 2.7k
Meike E. W. Logtenberg Netherlands 7 808 0.7× 1.0k 0.8× 649 0.9× 292 0.5× 154 0.8× 10 1.9k

Countries citing papers authored by Grégory Driessens

Since Specialization
Citations

This map shows the geographic impact of Grégory Driessens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grégory Driessens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grégory Driessens more than expected).

Fields of papers citing papers by Grégory Driessens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grégory Driessens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grégory Driessens. The network helps show where Grégory Driessens may publish in the future.

Co-authorship network of co-authors of Grégory Driessens

This figure shows the co-authorship network connecting the top 25 collaborators of Grégory Driessens. A scholar is included among the top collaborators of Grégory Driessens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grégory Driessens. Grégory Driessens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Stephanie, Iain Welsby, Nicolas Rosewick, et al.. (2023). 74 Abstract withdrawn. SHILAP Revista de lepidopterología. A84–A84. 1 indexed citations
2.
Minnie, Simone A., Kathleen S. Ensbey, Stuart D. Olver, et al.. (2022). TIGIT inhibition and lenalidomide synergistically promote antimyeloma immune responses after stem cell transplantation in mice. Journal of Clinical Investigation. 133(4). 11 indexed citations
3.
Crosignani, Stefano, et al.. (2019). Inhibition of Tryptophan-Dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors. Cancer Immunology Research. 8(1). 32–45. 55 indexed citations
4.
Sunseri, Nicole, Xiufen Chen, Noémie Wald, et al.. (2019). Beyond PD-1: Investigating the Therapeutic Potential of TIGIT Blockade in DLBCL. Blood. 134(Supplement_1). 391–391. 4 indexed citations
5.
Driessens, Grégory. (2014). Deciphering Tumor Growth by Clonal Analysis. Critical Reviews™ in Oncogenesis. 19(5). 317–325. 4 indexed citations
6.
Boumahdi, Soufiane, Grégory Driessens, Gaëlle Lapouge, et al.. (2014). SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Nature. 511(7508). 246–250. 521 indexed citations breakdown →
7.
Driessens, Grégory, Stefano Crosignani, Michel Detheux, Benoı̂t Van den Eynde, & Sandra Cauwenberghs. (2014). Preclinical assessment of a novel small molecule inhibitor of indoleamine 2,3-dioxygenase 1 (IDO1). Journal for ImmunoTherapy of Cancer. 2(Suppl 3). P195–P195. 1 indexed citations
8.
Driessens, Grégory, et al.. (2012). Defining the mode of tumour growth by clonal analysis. Nature. 488(7412). 527–530. 547 indexed citations breakdown →
9.
Zheng, Yan, Yuanyuan Zha, Grégory Driessens, Frederick L. Locke, & Thomas F. Gajewski. (2012). Transcriptional regulator early growth response gene 2 (Egr2) is required for T cell anergy in vitro and in vivo. The Journal of Experimental Medicine. 209(12). 2157–2163. 84 indexed citations
10.
Beck, Benjamin, Grégory Driessens, Steven Goossens, et al.. (2011). A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours. Nature. 478(7369). 399–403. 375 indexed citations
11.
Driessens, Grégory, et al.. (2010). Development of a successful antitumor therapeutic model combining in vivo dendritic cell vaccination with tumor irradiation and intratumoral GM-CSF delivery. Cancer Immunology Immunotherapy. 60(2). 273–281. 24 indexed citations
12.
Driessens, Grégory, Yan Zheng, Frederick L. Locke, et al.. (2010). β-Catenin Inhibits T Cell Activation by Selective Interference with Linker for Activation of T Cells–Phospholipase C-γ1 Phosphorylation. The Journal of Immunology. 186(2). 784–790. 39 indexed citations
13.
Driessens, Grégory & Thomas F. Gajewski. (2009). Beta-catenin negatively regulates peripheral T cell activation (35.36). The Journal of Immunology. 182(Supplement_1). 35.36–35.36. 2 indexed citations
14.
Driessens, Grégory, et al.. (2009). Synergy Between Dendritic Cells and GM–CSF-secreting Tumor Cells for the Treatment of a Murine Renal Cell Carcinoma. Journal of Immunotherapy. 32(2). 140–144. 7 indexed citations
15.
Driessens, Grégory, Justin Kline, & Thomas F. Gajewski. (2009). Costimulatory and coinhibitory receptors in anti‐tumor immunity. Immunological Reviews. 229(1). 126–144. 203 indexed citations
16.
Cham, Candace M., Grégory Driessens, James P. O’Keefe, & Thomas F. Gajewski. (2008). Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells. European Journal of Immunology. 38(9). 2438–2450. 310 indexed citations
17.
Driessens, Grégory, Laurence Gordower, Patrick Stordeur, et al.. (2008). Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8+ T cell recruitment and low relative regulatory T cell infiltration. Cancer Immunology Immunotherapy. 57(12). 1745–1756. 18 indexed citations
18.
Driessens, Grégory, et al.. (2004). Highly Successful Therapeutic Vaccinations Combining Dendritic Cells and Tumor Cells Secreting Granulocyte Macrophage Colony-stimulating Factor. Cancer Research. 64(22). 8435–8442. 11 indexed citations
19.
Driessens, Grégory, Laura Harsan, Bernard Robaye, et al.. (2003). Micronuclei to detect in vivo chemotherapy damage in a p53 mutated solid tumour. British Journal of Cancer. 89(4). 727–729. 17 indexed citations
20.
Driessens, Grégory, et al.. (2003). Assessment of In Vivo Chemotherapy‐Induced DNA Damage in a p53‐Mutated Rat Tumor by Micronuclei Assay. Annals of the New York Academy of Sciences. 1010(1). 775–779. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rubén A. Bartolomé Breakdown of academic impact, for papers by Jürgen Dittmer Breakdown of academic impact, for papers by Kristin J. Hope Breakdown of academic impact, for papers by Stephin J. Vervoort Breakdown of academic impact, for papers by Klara Balint Breakdown of academic impact, for papers by Steven Goossens Breakdown of academic impact, for papers by Isabelle Bourget Breakdown of academic impact, for papers by Koichi Sakakura Breakdown of academic impact, for papers by Dolores Martínez Breakdown of academic impact, for papers by Meike E. W. Logtenberg
Rankless by CCL
2026